SlideShare a Scribd company logo

Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL

•Download as PPT, PDF•
•
PVI, PeerView Institute for Medical Education
PVI, PeerView Institute for Medical Education

Chair, John C. Byrd, MD, and Kami Maddocks, MD, discuss B-cell cancers in this CME/MOC activity titled “Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL.” For the full presentation and complete CME/MOC information, and to apply for credit, please visit us at http://bit.ly/3Gv1ZZ4. CME/MOC credit will be available until February 1, 2024.

Health & Medicine
1 of 47
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL

Recommended

Zs 0018 Kazna Za Oholog Pukovnika
Zs 0018 Kazna Za Oholog PukovnikaZs 0018 Kazna Za Oholog Pukovnika
Zs 0018 Kazna Za Oholog PukovnikaTompa *
 
Crafting the New Treatment Mix in CLL: Pharmacist Insights on Delivering Effe...
Crafting the New Treatment Mix in CLL: Pharmacist Insights on Delivering Effe...Crafting the New Treatment Mix in CLL: Pharmacist Insights on Delivering Effe...
Crafting the New Treatment Mix in CLL: Pharmacist Insights on Delivering Effe...PVI, PeerView Institute for Medical Education
 
0361 Sedma Runda
0361 Sedma Runda0361 Sedma Runda
0361 Sedma RundaTompa *
 
Zagor Ludens Kolor 006 - Duhovi Diging Bila
Zagor Ludens Kolor 006 - Duhovi Diging BilaZagor Ludens Kolor 006 - Duhovi Diging Bila
Zagor Ludens Kolor 006 - Duhovi Diging BilaStripovizijacom
 
0769. OPKLADA ZA STRAH
0769. OPKLADA ZA STRAH0769. OPKLADA ZA STRAH
0769. OPKLADA ZA STRAHTompa *
 
Zs 0938 teks viler - bekstvo iz andervila (scanturion & emeri)(5 mb)
Zs 0938 teks viler - bekstvo iz andervila (scanturion & emeri)(5 mb)Zs 0938 teks viler - bekstvo iz andervila (scanturion & emeri)(5 mb)
Zs 0938 teks viler - bekstvo iz andervila (scanturion & emeri)(5 mb)zoran radovic
 
ZS - 0332 - Komandant Mark - CAROBNA KNJIGA
ZS - 0332 - Komandant Mark - CAROBNA KNJIGAZS - 0332 - Komandant Mark - CAROBNA KNJIGA
ZS - 0332 - Komandant Mark - CAROBNA KNJIGAStripovizijacom
 
The lion king
The lion kingThe lion king
The lion kingLUIS NARBONA
 

Recommended

Zs 0018 Kazna Za Oholog Pukovnika
Zs 0018 Kazna Za Oholog PukovnikaZs 0018 Kazna Za Oholog Pukovnika
Zs 0018 Kazna Za Oholog PukovnikaTompa *
 
Crafting the New Treatment Mix in CLL: Pharmacist Insights on Delivering Effe...
Crafting the New Treatment Mix in CLL: Pharmacist Insights on Delivering Effe...Crafting the New Treatment Mix in CLL: Pharmacist Insights on Delivering Effe...
Crafting the New Treatment Mix in CLL: Pharmacist Insights on Delivering Effe...PVI, PeerView Institute for Medical Education
 
0361 Sedma Runda
0361 Sedma Runda0361 Sedma Runda
0361 Sedma RundaTompa *
 
Zagor Ludens Kolor 006 - Duhovi Diging Bila
Zagor Ludens Kolor 006 - Duhovi Diging BilaZagor Ludens Kolor 006 - Duhovi Diging Bila
Zagor Ludens Kolor 006 - Duhovi Diging BilaStripovizijacom
 
0769. OPKLADA ZA STRAH
0769. OPKLADA ZA STRAH0769. OPKLADA ZA STRAH
0769. OPKLADA ZA STRAHTompa *
 
Zs 0938 teks viler - bekstvo iz andervila (scanturion & emeri)(5 mb)
Zs 0938 teks viler - bekstvo iz andervila (scanturion & emeri)(5 mb)Zs 0938 teks viler - bekstvo iz andervila (scanturion & emeri)(5 mb)
Zs 0938 teks viler - bekstvo iz andervila (scanturion & emeri)(5 mb)zoran radovic
 
ZS - 0332 - Komandant Mark - CAROBNA KNJIGA
ZS - 0332 - Komandant Mark - CAROBNA KNJIGAZS - 0332 - Komandant Mark - CAROBNA KNJIGA
ZS - 0332 - Komandant Mark - CAROBNA KNJIGAStripovizijacom
 
The lion king
The lion kingThe lion king
The lion kingLUIS NARBONA
 
TTF.TAAO.04
TTF.TAAO.04TTF.TAAO.04
TTF.TAAO.04Arcee327
 
0017. Klark Siti
0017. Klark Siti0017. Klark Siti
0017. Klark SitiTompa *
 
TF.ROTF.OMS-NFROS.02
TF.ROTF.OMS-NFROS.02TF.ROTF.OMS-NFROS.02
TF.ROTF.OMS-NFROS.02Arcee327
 
Zs 1060 kapetan miki - mackova banda (imperrio & zexx & emeri)(5 mb)
Zs 1060 kapetan miki - mackova banda (imperrio & zexx & emeri)(5 mb)Zs 1060 kapetan miki - mackova banda (imperrio & zexx & emeri)(5 mb)
Zs 1060 kapetan miki - mackova banda (imperrio & zexx & emeri)(5 mb)zoran radovic
 
0464. naivčine iz elkinsa
0464. naivčine iz elkinsa0464. naivčine iz elkinsa
0464. naivčine iz elkinsaTompa *
 
0770. BRODOLOM NA MISURIJU
0770. BRODOLOM NA MISURIJU0770. BRODOLOM NA MISURIJU
0770. BRODOLOM NA MISURIJUTompa *
 
南安方言志
南安方言志南安方言志
南安方言志terrifuc
 
ZS - 0371 - Teks Viler - PAT SREDJUJE RACUNE
ZS - 0371 - Teks Viler - PAT SREDJUJE RACUNEZS - 0371 - Teks Viler - PAT SREDJUJE RACUNE
ZS - 0371 - Teks Viler - PAT SREDJUJE RACUNEStripovizijacom
 
Hizb 3
Hizb 3Hizb 3
Hizb 3steka36
 
0859. TURNIR U DARKVUDU
0859. TURNIR U DARKVUDU0859. TURNIR U DARKVUDU
0859. TURNIR U DARKVUDUTompa *
 
0665. SLOMLJENO KOPLJE
0665. SLOMLJENO KOPLJE0665. SLOMLJENO KOPLJE
0665. SLOMLJENO KOPLJETompa *
 
298. Zlato Inka
298. Zlato Inka298. Zlato Inka
298. Zlato InkaDino dino
 
642 carobna suska jaga
642 carobna suska jaga642 carobna suska jaga
642 carobna suska jagaMilenko Gavric
 
Dok holidej 210 lovci bufala
Dok holidej 210 lovci bufala Dok holidej 210 lovci bufala
Dok holidej 210 lovci bufala zoran radovic
 
Pddu cachoeirinha - rs - transcrição do site do municipio - em 20092013 agea
Pddu cachoeirinha - rs - transcrição do site do municipio - em 20092013 ageaPddu cachoeirinha - rs - transcrição do site do municipio - em 20092013 agea
Pddu cachoeirinha - rs - transcrição do site do municipio - em 20092013 ageaAssociação Geologos Engenheiros Arquitetos
 
TTF.RID.ANNU2012
TTF.RID.ANNU2012TTF.RID.ANNU2012
TTF.RID.ANNU2012Arcee327
 
TTF.MD.01
TTF.MD.01TTF.MD.01
TTF.MD.01Arcee327
 
Veliki Blek L 086 - Gavrani i vrac
Veliki Blek L 086 - Gavrani i vracVeliki Blek L 086 - Gavrani i vrac
Veliki Blek L 086 - Gavrani i vracStripovizijacom
 
تفسير الجزء الحادي والعشرون
تفسير الجزء الحادي والعشرونتفسير الجزء الحادي والعشرون
تفسير الجزء الحادي والعشرونMohammad Ihmeidan
 
Zagor vec 058 vampirica ilenija
Zagor vec 058 vampirica ilenijaZagor vec 058 vampirica ilenija
Zagor vec 058 vampirica ilenijaDino dino
 
Exploring the Evidence: Improving Cardiovascular Outcomes and the Role of Wei...
Exploring the Evidence: Improving Cardiovascular Outcomes and the Role of Wei...Exploring the Evidence: Improving Cardiovascular Outcomes and the Role of Wei...
Exploring the Evidence: Improving Cardiovascular Outcomes and the Role of Wei...PVI, PeerView Institute for Medical Education
 
Interdisciplinary Approaches to Management of Immune-Mediated Inflammatory Di...
Interdisciplinary Approaches to Management of Immune-Mediated Inflammatory Di...Interdisciplinary Approaches to Management of Immune-Mediated Inflammatory Di...
Interdisciplinary Approaches to Management of Immune-Mediated Inflammatory Di...PVI, PeerView Institute for Medical Education
 

More Related Content

What's hot

TTF.TAAO.04
TTF.TAAO.04TTF.TAAO.04
TTF.TAAO.04Arcee327
 
0017. Klark Siti
0017. Klark Siti0017. Klark Siti
0017. Klark SitiTompa *
 
TF.ROTF.OMS-NFROS.02
TF.ROTF.OMS-NFROS.02TF.ROTF.OMS-NFROS.02
TF.ROTF.OMS-NFROS.02Arcee327
 
Zs 1060 kapetan miki - mackova banda (imperrio & zexx & emeri)(5 mb)
Zs 1060 kapetan miki - mackova banda (imperrio & zexx & emeri)(5 mb)Zs 1060 kapetan miki - mackova banda (imperrio & zexx & emeri)(5 mb)
Zs 1060 kapetan miki - mackova banda (imperrio & zexx & emeri)(5 mb)zoran radovic
 
0464. naivčine iz elkinsa
0464. naivčine iz elkinsa0464. naivčine iz elkinsa
0464. naivčine iz elkinsaTompa *
 
0770. BRODOLOM NA MISURIJU
0770. BRODOLOM NA MISURIJU0770. BRODOLOM NA MISURIJU
0770. BRODOLOM NA MISURIJUTompa *
 
南安方言志
南安方言志南安方言志
南安方言志terrifuc
 
ZS - 0371 - Teks Viler - PAT SREDJUJE RACUNE
ZS - 0371 - Teks Viler - PAT SREDJUJE RACUNEZS - 0371 - Teks Viler - PAT SREDJUJE RACUNE
ZS - 0371 - Teks Viler - PAT SREDJUJE RACUNEStripovizijacom
 
0859. TURNIR U DARKVUDU
0859. TURNIR U DARKVUDU0859. TURNIR U DARKVUDU
0859. TURNIR U DARKVUDUTompa *
 
0665. SLOMLJENO KOPLJE
0665. SLOMLJENO KOPLJE0665. SLOMLJENO KOPLJE
0665. SLOMLJENO KOPLJETompa *
 
298. Zlato Inka
298. Zlato Inka298. Zlato Inka
298. Zlato InkaDino dino
 
642 carobna suska jaga
642 carobna suska jaga642 carobna suska jaga
642 carobna suska jagaMilenko Gavric
 
Dok holidej 210 lovci bufala
Dok holidej 210 lovci bufala Dok holidej 210 lovci bufala
Dok holidej 210 lovci bufala zoran radovic
 
TTF.RID.ANNU2012
TTF.RID.ANNU2012TTF.RID.ANNU2012
TTF.RID.ANNU2012Arcee327
 
Veliki Blek L 086 - Gavrani i vrac
Veliki Blek L 086 - Gavrani i vracVeliki Blek L 086 - Gavrani i vrac
Veliki Blek L 086 - Gavrani i vracStripovizijacom
 
تفسير الجزء الحادي والعشرون
تفسير الجزء الحادي والعشرونتفسير الجزء الحادي والعشرون
تفسير الجزء الحادي والعشرونMohammad Ihmeidan
 
Zagor vec 058 vampirica ilenija
Zagor vec 058 vampirica ilenijaZagor vec 058 vampirica ilenija
Zagor vec 058 vampirica ilenijaDino dino
 

What's hot (20)

TTF.TAAO.04
TTF.TAAO.04TTF.TAAO.04
TTF.TAAO.04
 
0017. Klark Siti
0017. Klark Siti0017. Klark Siti
0017. Klark Siti
 
TF.ROTF.OMS-NFROS.02
TF.ROTF.OMS-NFROS.02TF.ROTF.OMS-NFROS.02
TF.ROTF.OMS-NFROS.02
 
Zs 1060 kapetan miki - mackova banda (imperrio & zexx & emeri)(5 mb)
Zs 1060 kapetan miki - mackova banda (imperrio & zexx & emeri)(5 mb)Zs 1060 kapetan miki - mackova banda (imperrio & zexx & emeri)(5 mb)
Zs 1060 kapetan miki - mackova banda (imperrio & zexx & emeri)(5 mb)
 
0464. naivčine iz elkinsa
0464. naivčine iz elkinsa0464. naivčine iz elkinsa
0464. naivčine iz elkinsa
 
0770. BRODOLOM NA MISURIJU
0770. BRODOLOM NA MISURIJU0770. BRODOLOM NA MISURIJU
0770. BRODOLOM NA MISURIJU
 
南安方言志
南安方言志南安方言志
南安方言志
 
ZS - 0371 - Teks Viler - PAT SREDJUJE RACUNE
ZS - 0371 - Teks Viler - PAT SREDJUJE RACUNEZS - 0371 - Teks Viler - PAT SREDJUJE RACUNE
ZS - 0371 - Teks Viler - PAT SREDJUJE RACUNE
 
Hizb 3
Hizb 3Hizb 3
Hizb 3
 
0859. TURNIR U DARKVUDU
0859. TURNIR U DARKVUDU0859. TURNIR U DARKVUDU
0859. TURNIR U DARKVUDU
 
0665. SLOMLJENO KOPLJE
0665. SLOMLJENO KOPLJE0665. SLOMLJENO KOPLJE
0665. SLOMLJENO KOPLJE
 
298. Zlato Inka
298. Zlato Inka298. Zlato Inka
298. Zlato Inka
 
642 carobna suska jaga
642 carobna suska jaga642 carobna suska jaga
642 carobna suska jaga
 
Dok holidej 210 lovci bufala
Dok holidej 210 lovci bufala Dok holidej 210 lovci bufala
Dok holidej 210 lovci bufala
 
Pddu cachoeirinha - rs - transcrição do site do municipio - em 20092013 agea
Pddu cachoeirinha - rs - transcrição do site do municipio - em 20092013 ageaPddu cachoeirinha - rs - transcrição do site do municipio - em 20092013 agea
Pddu cachoeirinha - rs - transcrição do site do municipio - em 20092013 agea
 
TTF.RID.ANNU2012
TTF.RID.ANNU2012TTF.RID.ANNU2012
TTF.RID.ANNU2012
 
TTF.MD.01
TTF.MD.01TTF.MD.01
TTF.MD.01
 
Veliki Blek L 086 - Gavrani i vrac
Veliki Blek L 086 - Gavrani i vracVeliki Blek L 086 - Gavrani i vrac
Veliki Blek L 086 - Gavrani i vrac
 
تفسير الجزء الحادي والعشرون
تفسير الجزء الحادي والعشرونتفسير الجزء الحادي والعشرون
تفسير الجزء الحادي والعشرون
 
Zagor vec 058 vampirica ilenija
Zagor vec 058 vampirica ilenijaZagor vec 058 vampirica ilenija
Zagor vec 058 vampirica ilenija
 

More from PVI, PeerView Institute for Medical Education

More from PVI, PeerView Institute for Medical Education (20)

Exploring the Evidence: Improving Cardiovascular Outcomes and the Role of Wei...
Exploring the Evidence: Improving Cardiovascular Outcomes and the Role of Wei...Exploring the Evidence: Improving Cardiovascular Outcomes and the Role of Wei...
Exploring the Evidence: Improving Cardiovascular Outcomes and the Role of Wei...
 
Interdisciplinary Approaches to Management of Immune-Mediated Inflammatory Di...
Interdisciplinary Approaches to Management of Immune-Mediated Inflammatory Di...Interdisciplinary Approaches to Management of Immune-Mediated Inflammatory Di...
Interdisciplinary Approaches to Management of Immune-Mediated Inflammatory Di...
 
Treatment Advances and Individualized Therapeutic Strategies in Prostate Canc...
Treatment Advances and Individualized Therapeutic Strategies in Prostate Canc...Treatment Advances and Individualized Therapeutic Strategies in Prostate Canc...
Treatment Advances and Individualized Therapeutic Strategies in Prostate Canc...
 
Charting a New Path to Better Outcomes With TROP2-Targeting ADCs in Lung Canc...
Charting a New Path to Better Outcomes With TROP2-Targeting ADCs in Lung Canc...Charting a New Path to Better Outcomes With TROP2-Targeting ADCs in Lung Canc...
Charting a New Path to Better Outcomes With TROP2-Targeting ADCs in Lung Canc...
 
Biologics in CRSwNP: Putting a Paradigm Shift Into Practice
Biologics in CRSwNP: Putting a Paradigm Shift Into PracticeBiologics in CRSwNP: Putting a Paradigm Shift Into Practice
Biologics in CRSwNP: Putting a Paradigm Shift Into Practice
 
Biologics in CRSwNP: Putting a Paradigm Shift Into Practice
Biologics in CRSwNP: Putting a Paradigm Shift Into PracticeBiologics in CRSwNP: Putting a Paradigm Shift Into Practice
Biologics in CRSwNP: Putting a Paradigm Shift Into Practice
 
Prescriptions for Successful Myeloma Care: Pharmacy Strategies for Delivering...
Prescriptions for Successful Myeloma Care: Pharmacy Strategies for Delivering...Prescriptions for Successful Myeloma Care: Pharmacy Strategies for Delivering...
Prescriptions for Successful Myeloma Care: Pharmacy Strategies for Delivering...
 
Precision & Progress Against NF1: Solutions for Better Outcomes With MEKi & M...
Precision & Progress Against NF1: Solutions for Better Outcomes With MEKi & M...Precision & Progress Against NF1: Solutions for Better Outcomes With MEKi & M...
Precision & Progress Against NF1: Solutions for Better Outcomes With MEKi & M...
 
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...
 
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...
Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...
 
Advancing ADCs in Gynecologic Cancers: Expert Insights on Recent Evidence, Im...
Advancing ADCs in Gynecologic Cancers: Expert Insights on Recent Evidence, Im...Advancing ADCs in Gynecologic Cancers: Expert Insights on Recent Evidence, Im...
Advancing ADCs in Gynecologic Cancers: Expert Insights on Recent Evidence, Im...
 
Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...
Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...
Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...
 
Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...
Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...
Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...
 
Democratizing the CAR-T Experience: The Principles and Practice of Outpatient...
Democratizing the CAR-T Experience: The Principles and Practice of Outpatient...Democratizing the CAR-T Experience: The Principles and Practice of Outpatient...
Democratizing the CAR-T Experience: The Principles and Practice of Outpatient...
 
Democratizing the CAR-T Experience: The Principles and Practice of Outpatient...
Democratizing the CAR-T Experience: The Principles and Practice of Outpatient...Democratizing the CAR-T Experience: The Principles and Practice of Outpatient...
Democratizing the CAR-T Experience: The Principles and Practice of Outpatient...
 
The Convergence of Interventional Radiologists and Oncologists in HCC: Shared...
The Convergence of Interventional Radiologists and Oncologists in HCC: Shared...The Convergence of Interventional Radiologists and Oncologists in HCC: Shared...
The Convergence of Interventional Radiologists and Oncologists in HCC: Shared...
 
Navigating Narcolepsy in Family Practice: Patient-Centered Strategies to Opti...
Navigating Narcolepsy in Family Practice: Patient-Centered Strategies to Opti...Navigating Narcolepsy in Family Practice: Patient-Centered Strategies to Opti...
Navigating Narcolepsy in Family Practice: Patient-Centered Strategies to Opti...
 
New Chapters in the Immunotherapy Story for Melanoma: Collaborative Care and ...
New Chapters in the Immunotherapy Story for Melanoma: Collaborative Care and ...New Chapters in the Immunotherapy Story for Melanoma: Collaborative Care and ...
New Chapters in the Immunotherapy Story for Melanoma: Collaborative Care and ...
 
Unraveling the Complex Choices in Early Breast Cancer: A Roadmap to Informed ...
Unraveling the Complex Choices in Early Breast Cancer: A Roadmap to Informed ...Unraveling the Complex Choices in Early Breast Cancer: A Roadmap to Informed ...
Unraveling the Complex Choices in Early Breast Cancer: A Roadmap to Informed ...
 
From Resistance to Resilience in R/R CLL: Sequencing Strategies for Achieving...
From Resistance to Resilience in R/R CLL: Sequencing Strategies for Achieving...From Resistance to Resilience in R/R CLL: Sequencing Strategies for Achieving...
From Resistance to Resilience in R/R CLL: Sequencing Strategies for Achieving...
 

Recently uploaded

Phytochemical profile and antioxidant activity of two varieties of dates (Pho...
Phytochemical profile and antioxidant activity of two varieties of dates (Pho...Phytochemical profile and antioxidant activity of two varieties of dates (Pho...
Phytochemical profile and antioxidant activity of two varieties of dates (Pho...ilham guercif
 
traitement orthopédique des fractures de la face.pptx
traitement orthopédique des fractures de la face.pptxtraitement orthopédique des fractures de la face.pptx
traitement orthopédique des fractures de la face.pptxMohamedAbdelmoumeneB
 
Syndrome coronarien aigu avec ST plus ST
Syndrome coronarien aigu avec ST plus STSyndrome coronarien aigu avec ST plus ST
Syndrome coronarien aigu avec ST plus STFatimaOulhouss1
 
Brevets et innovation contre le cancer -
Brevets et innovation contre le cancer -Brevets et innovation contre le cancer -
Brevets et innovation contre le cancer -benj_2
 
antalgique cours 3 année faculté .pptx
antalgique cours 3 année faculté .pptxantalgique cours 3 année faculté .pptx
antalgique cours 3 année faculté .pptxDjacemBelmokre
 
Traitement_Palu Grave_ Janv 2023..pdf RDc
Traitement_Palu Grave_ Janv 2023..pdf RDcTraitement_Palu Grave_ Janv 2023..pdf RDc
Traitement_Palu Grave_ Janv 2023..pdf RDcnuriel683
 
cardiac manifestations in auto-immune diseases by Dr Silini.pptx
cardiac manifestations in auto-immune diseases by Dr Silini.pptxcardiac manifestations in auto-immune diseases by Dr Silini.pptx
cardiac manifestations in auto-immune diseases by Dr Silini.pptxsilinianfel
 
CAT devant une Thrombose veineuse superficielle .pptx
CAT devant une Thrombose veineuse superficielle .pptxCAT devant une Thrombose veineuse superficielle .pptx
CAT devant une Thrombose veineuse superficielle .pptxsilinianfel
 
Les-articulateurs-en-prothèse-totale-adjointe-A.Hamizi.pdf
Les-articulateurs-en-prothèse-totale-adjointe-A.Hamizi.pdfLes-articulateurs-en-prothèse-totale-adjointe-A.Hamizi.pdf
Les-articulateurs-en-prothèse-totale-adjointe-A.Hamizi.pdfkorialoverarmy
 

Recently uploaded (9)

Phytochemical profile and antioxidant activity of two varieties of dates (Pho...
Phytochemical profile and antioxidant activity of two varieties of dates (Pho...Phytochemical profile and antioxidant activity of two varieties of dates (Pho...
Phytochemical profile and antioxidant activity of two varieties of dates (Pho...
 
traitement orthopédique des fractures de la face.pptx
traitement orthopédique des fractures de la face.pptxtraitement orthopédique des fractures de la face.pptx
traitement orthopédique des fractures de la face.pptx
 
Syndrome coronarien aigu avec ST plus ST
Syndrome coronarien aigu avec ST plus STSyndrome coronarien aigu avec ST plus ST
Syndrome coronarien aigu avec ST plus ST
 
Brevets et innovation contre le cancer -
Brevets et innovation contre le cancer -Brevets et innovation contre le cancer -
Brevets et innovation contre le cancer -
 
antalgique cours 3 année faculté .pptx
antalgique cours 3 année faculté .pptxantalgique cours 3 année faculté .pptx
antalgique cours 3 année faculté .pptx
 
Traitement_Palu Grave_ Janv 2023..pdf RDc
Traitement_Palu Grave_ Janv 2023..pdf RDcTraitement_Palu Grave_ Janv 2023..pdf RDc
Traitement_Palu Grave_ Janv 2023..pdf RDc
 
cardiac manifestations in auto-immune diseases by Dr Silini.pptx
cardiac manifestations in auto-immune diseases by Dr Silini.pptxcardiac manifestations in auto-immune diseases by Dr Silini.pptx
cardiac manifestations in auto-immune diseases by Dr Silini.pptx
 
CAT devant une Thrombose veineuse superficielle .pptx
CAT devant une Thrombose veineuse superficielle .pptxCAT devant une Thrombose veineuse superficielle .pptx
CAT devant une Thrombose veineuse superficielle .pptx
 
Les-articulateurs-en-prothèse-totale-adjointe-A.Hamizi.pdf
Les-articulateurs-en-prothèse-totale-adjointe-A.Hamizi.pdfLes-articulateurs-en-prothèse-totale-adjointe-A.Hamizi.pdf
Les-articulateurs-en-prothèse-totale-adjointe-A.Hamizi.pdf